Niagen Bioscience, Inc. (NASDAQ: NAGE) announced that the U.S. Food and Drug Administration granted Rare Pediatric Disease designation to its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE